BioMérieux S.A.
BIM
Rangering i aksjer
#1755
bioMérieux S.A. is a global entity operating across the Americas, Europe, the... bioMérieux S.A. is a global entity operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, specializing in the development and production of in vitro diagnostic solutions. The company's sophisticated systems utilize biological samples to identify infectious diseases, cardiovascular conditions, and various forms of cancer. Additionally, bioMérieux provides essential microbiological testing services for the manufacturing sectors, primarily serving the food, pharmaceutical, cosmetics, and veterinary industries. Its client base includes clinical and hospital laboratories, medical practitioners, blood banks, and industrial quality control facilities. Founded in 1963, originally under the name B-D Mérieux, bioMérieux S.A. maintains its headquarters in Marcy l'Etoile, France, and functions as a subsidiary of Institut Mérieux SA.
Aksjekurs
$104.62
Markedsverdi
$12.31B
Endring (1 dag)
1.15%
Endring (1 år)
-18.08%
Land
FR
Handel BioMérieux S.A. (BIM)
Kategori
Healthcare
Historikk for aksjesplitt for BioMérieux S.A. (BIM)
Aksjen BioMérieux S.A. (symbol: BIM) har gjennomgått totalt 1 aksjesplitt.
Den nyeste splittelsen skjedde Sep 20, 2017.
Én BIM-aksje kjøpt før Sep 20, 2017 tilsvarer i dag 3 BIM-aksjer.
Den nyeste splittelsen skjedde Sep 20, 2017.
Én BIM-aksje kjøpt før Sep 20, 2017 tilsvarer i dag 3 BIM-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| 2017-09-20 | 3:1 | x3 | x3 |
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 8 | x34 |
US
|
|
| 7 | x47 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CN
|
|
| 1 | x1 |
US
|
